100 related articles for article (PubMed ID: 26812797)
1. Patient-performed extraction of faecal calprotectin.
Kristensen V; Lauritzen T; Jelsness-Jørgensen LP; Frigstad SO; Corwin C; Moum B
Clin Chem Lab Med; 2016 Aug; 54(8):1357-63. PubMed ID: 26812797
[TBL] [Abstract][Full Text] [Related]
2. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
Kristensen V; Lauritzen T; Jelsness-JØrgensen LP; Moum B
Scand J Clin Lab Invest; 2015 Sep; 75(5):355-61. PubMed ID: 25856663
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
[TBL] [Abstract][Full Text] [Related]
5. Comparison of faecal calprotectin using two collection and extraction strategies for the BÜHLMANN CALEX® Cap - possible implications for clinical cut-offs?
Bruce H; Osypiw J; Prajapati-Jha G; O'Driscoll S; Brealey M; Benton SC
Ann Clin Biochem; 2023 Jul; 60(4):236-242. PubMed ID: 36750426
[TBL] [Abstract][Full Text] [Related]
6. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
7. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
Gisbert JP; McNicholl AG
Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
[TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
[TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
Coorevits L; Baert FJ; Vanpoucke HJ
Clin Chem Lab Med; 2013 Apr; 51(4):825-31. PubMed ID: 23001318
[TBL] [Abstract][Full Text] [Related]
10. What is the faecal calprotectin test?
Drug Ther Bull; 2014 Sep; 52(9):102-4. PubMed ID: 25213590
[TBL] [Abstract][Full Text] [Related]
11. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits.
Whitehead SJ; French J; Brookes MJ; Ford C; Gama R
Ann Clin Biochem; 2013 Jan; 50(Pt 1):53-61. PubMed ID: 23129721
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of calprotectin in faeces].
Jahnsen J; Røseth AG; Aadland E
Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Quantum Blue® rapid test for faecal calprotectin.
Wassell J; Wallage M; Brewer E
Ann Clin Biochem; 2012 Jan; 49(Pt 1):55-8. PubMed ID: 21930735
[TBL] [Abstract][Full Text] [Related]
14. Do not forget about pre-analytics in faecal calprotectin measurement!
Oyaert M; Van den Bremt S; Boel A; Bossuyt X; Van Hoovels L
Clin Chim Acta; 2017 Oct; 473():124-126. PubMed ID: 28847684
[No Abstract] [Full Text] [Related]
15. BÜHLMANN Calex® Cap for the faecal extraction of calprotectin - Fit for purpose?
Kaur S; Ford C; Gama R
Ann Clin Biochem; 2020 Jul; 57(4):332-333. PubMed ID: 32429682
[No Abstract] [Full Text] [Related]
16. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Schröder O; Naumann M; Shastri Y; Povse N; Stein J
Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
[TBL] [Abstract][Full Text] [Related]
17. The Reliability of Patient-Performed Fecal Calprotectin Testing in Inflammatory Bowel Disease.
Dijkhuis LEJL; Crouwel F; Duijvestein M; Buiter HJC; de Boer NK; Hamer HM
J Appl Lab Med; 2023 Mar; 8(2):319-329. PubMed ID: 36512478
[TBL] [Abstract][Full Text] [Related]
18. Paediatric reference ranges for faecal calprotectin: a UK study.
Davidson F; Lock RJ
Ann Clin Biochem; 2017 Mar; 54(2):214-218. PubMed ID: 27141011
[TBL] [Abstract][Full Text] [Related]
19. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
Zippi M; Al Ansari N; Siliquini F; Severi C; Kagarmanova A; Maffia C; Parlanti S; Garbarino V; Maccioni F
Clin Ter; 2010; 161(2):e53-6. PubMed ID: 20499020
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
Grad C; David L; Portincasa P; Dumitraşcu DL
Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]